NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,131 filers reported holding NOVARTIS A G in Q1 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,732,000 | +7.0% | 19,800 | 0.0% | 0.75% | +1.9% |
| Q3 2021 | $1,619,000 | -10.4% | 19,800 | 0.0% | 0.74% | -11.6% |
| Q2 2021 | $1,807,000 | +6.7% | 19,800 | 0.0% | 0.83% | -0.7% |
| Q1 2021 | $1,693,000 | -9.5% | 19,800 | 0.0% | 0.84% | -12.8% |
| Q4 2020 | $1,870,000 | +8.6% | 19,800 | 0.0% | 0.96% | -5.5% |
| Q3 2020 | $1,722,000 | -0.4% | 19,800 | 0.0% | 1.02% | -4.5% |
| Q2 2020 | $1,729,000 | +5.9% | 19,800 | 0.0% | 1.07% | -16.7% |
| Q1 2020 | $1,633,000 | -12.9% | 19,800 | 0.0% | 1.28% | +12.2% |
| Q4 2019 | $1,875,000 | +8.9% | 19,800 | 0.0% | 1.14% | +10.1% |
| Q3 2019 | $1,721,000 | -4.8% | 19,800 | 0.0% | 1.04% | +7.0% |
| Q2 2019 | $1,808,000 | -5.0% | 19,800 | 0.0% | 0.97% | -5.7% |
| Q1 2019 | $1,904,000 | +12.1% | 19,800 | 0.0% | 1.03% | -0.5% |
| Q4 2018 | $1,699,000 | -0.4% | 19,800 | 0.0% | 1.03% | +16.0% |
| Q3 2018 | $1,706,000 | +14.0% | 19,800 | 0.0% | 0.89% | -0.1% |
| Q2 2018 | $1,496,000 | – | 19,800 | – | 0.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |